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Ross River (RR) virus is an alphavirus endemic to Australia and New Guinea and is the aetiological agent of epidemic polyarthritis or RR
virus disease. Here we provide evidence that RR virus uses the collagen-binding a1h1 integrin as a cellular receptor. Infection could be
inhibited by collagen IV and antibodies specific for the h1 and a1 integrin proteins, and fibroblasts from a1-integrin/ mice were less
efficiently infected than wild-type fibroblasts. Soluble a1h1 integrin bound immobilized RR virus, and peptides representing the a1h1
integrin binding-site on collagen IV inhibited virus binding to cells. We speculate that two highly conserved regions within the cell-receptor
binding domain of E2 mimic collagen and provide access to cellular collagen-binding receptors.
D 2005 Elsevier Inc. All rights reserved.Keywords: Ross River virus; Receptor; a1h1 integrin; Collagen IVIntroduction
The genus Alphavirus in the family Togaviridae
represents a group of enveloped, positive-sense, single-
stranded RNA, arboviruses comprising over 40 known
members, which are maintained in nature by continuous
cycles of transmission between hematophagous arthropods
and vertebrate hosts (Peters and Dalrymple, 1990).
Alphaviruses are found on every continent of the world,
and based on phylogenetic analysis, have been grouped
into the Sindbis (SN) and recombinant virus group, the
Venezuelan and eastern equine encephalitis virus group,0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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alphaviruses (Powers et al., 2001). The first two groups
largely utilize birds as their natural enzootic vertebrate
hosts and segregate from the SF virus group, which
usually utilizes mammals (Linn et al., 2001). Several
alphaviruses also cause disease in humans primarily as a
result of epizootic infections. These include the American
encephalitic alphaviruses (Venezuelan, eastern, and western
equine encephalitis viruses) (Peters and Dalrymple, 1990)
and several viruses in the SF virus group that cause
arthritis/arthralgia, principally the Afro-Asian chikungunya
virus, the African o’nyong-nyong virus, and the Austral-
iasian Barmah Forest (BF) and Ross River (RR) viruses
(Suhrbier and Linn, 2004). RR virus is the aetiological
agent of epidemic polyarthritis or RR virus disease
(RRVD), which afflicts up to 8000 Australians annually.
In 1979/1980, an epidemic also swept through several
islands of the South Pacific resulting in tens of thousands05) 229 – 239
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by severe polyarthritis, which resolves over 3–6 months,
with about half the patients also experiencing a rash, fever,
myalgia, or fatigue (Mylonas et al., 2002). The arthritic
symptoms of RRVD are believed to be caused by
persistent productive infections of synovial macrophages
(Linn et al., 1996, 1998; Mateo et al., 2000; Soden et al.,
2000; Suhrbier and Linn, 2004).
The alphavirus genome encodes four non-structural
proteins, a capsid protein, and the spike proteins E1 and
E2, which are arranged as 240 heterodimers assembled
into 80 trimeric spikes on the virus surface. The E1
protein directs the membrane fusion process, and E2 is
thought to interact with the cellular receptor for the virus
(Hammar et al., 2003). The sequence around amino acids
170–220 of E2 is postulated to constitute a cell-receptor
binding domain for SN virus (Myles et al., 2003),
whereas the cell-receptor binding domain for RR virus
E2 appears to be extended towards the C-terminus and is
thought to lie between amino acids 170 and 262 (Davies
et al., 2000; Smith et al., 1995; Vrati et al., 1988). DC-
SIGN and L-SIGN have been shown to be attachment
receptors for SN virus probably by binding virion car-
bohydrate moieties (Klimstra et al., 2003). Heparin
sulphate has been implicated as a binding or capture
receptor for a number of alphaviruses including SN, SF,
and RR virus, with alphavirus binding to heparin sulphate
largely dependent on positively charged amino acids in E2
(Zhang et al., 2005). Increasing heparin sulphate binding
affinity often arises from mutations, which arise during
propagation of viruses in mammalian tissue culture
(Mandl et al., 2001; Smit et al., 2002). However, binding
to heparin sulphate is probably insufficient for viral entry
into cells, with the entry receptor likely to be a distinct
molecular entity (Heil et al., 2001). Such a cellular re-
ceptor for SN virus in mammalian cells has been reported
as the 67-kDa high-affinity laminin receptor (Wang et al.,
1992), and a 32 kDa receptor, which also appeared to be
a laminin receptor, was identified as a receptor for
Venezuelan equine encephalitis virus in mosquito cells
(Ludwig et al., 1996). Unknown 74-kDa and 110-kDa
proteins have also been reported as possible receptors for
SN virus on mouse neuroblastoma cells (Ubol and Griffin,
1991), as has a 63-kDa protein on chicken cells (Wang
et al., 1991). To our knowledge, no cellular receptor
for any alphaviruses in the SF group has so far been
reported.
Here we provide evidence that the a1h1 integrin
(also known as VLA-1 or CD49a/CD29) is a receptor
for RR virus on mammalian cells. The a1h1 integrin
has a high affinity for type IV collagen and is used by
adherent cells to bind to the extracellular matrix. The RR
virus E2 sequence between amino acids 170 and 262
contains two conserved regions that may fold to mimic
collagen and thereby mediate binding to cellular collagen
receptors.Results
RR virus infection is inhibited by collagen IV and heparin
We have previously noted that RR virus infects most
adherent cell lines, but few non-adherent cell lines,
suggesting that the cellular RR virus receptor might be
involved in binding to the extracellular matrix (ECM)
(Linn and Suhrbier, 1997; Linn et al., 1996). To test
whether soluble ECM proteins might block RR virus
infection and subsequent cytopathic effects (CPE), colla-
gen I, II, and IV, laminin, and fibronectin were incubated
with HeLa cells. RR virus (T48) was then added and
CPE was measured at 48 h post-infection. The multi-
plicity of infection (MOI) used in these experiments gave
>80% CPE after this period in the absence of ECM
proteins. Collagen IV was able to inhibit RR virus-
mediated CPE in a dose-dependent manner, whereas
laminin, fibronectin, and collagen I and II had no
detectable blocking activity (Fig. 1A), suggesting that
RR virus utilizes a cellular collagen IV receptor to infect
these cells. Collagen IV inhibited both RR virus derived
from mammalian HeLa cell cultures (Fig. 1A, RR
xHeLa) and RR virus derived from C6/36 mosquito cell
cultures (Fig. 1A, RR xC6/36). Infection by BF virus,
another arthritogenic virus from the SF virus group
(Flexman et al., 1998), was also inhibited by collagen
IV, but not laminin or fibronectin (Fig. 1A). Neither
infection by SF virus, nor the recently identified Southern
elephant seal (SES) virus could be appreciably blocked
by laminin, collagen I, or collagen IV (Fig. 1A),
illustrating that collagen IV is not a non-specific inhibitor
of alphavirus-induced CPE.
Several alphaviruses including RR virus are known to
bind heparin by virtue of positively charged amino acids
in E2 (Zhang et al., 2005), which are thought to be
selected for during extended passage in mammalian cells
(Mandl et al., 2001; Smit et al., 2002). To test for
heparin binding, virus and heparin were first co-
incubated for 1 h before addition to HeLa cell cultures.
CPE mediated by HeLa cell-derived RR virus (T48) and
BF virus, but not SF or SES virus, could be inhibited
by heparin (Fig. 1B). CPE mediated by SN and
RR14389, a human RR virus isolate, was also inhibited
by heparin (data not shown). After a single passage of
RR virus (T48) in C6/36 mosquito cells, a virus
population emerged that was no longer inhibited by
heparin (Fig. 1B, RR xC6/36). This is consistent with
previous studies (Mandl et al., 2001; Smit et al., 2002),
where only RR virus derived from passage in mamma-
lian cells could be effectively blocked by heparin.
Passage of RR virus in mosquito cells clearly results
in rapid loss of heparin binding. Importantly, both
infection by RR virus derived from mammalian cells
and RR virus derived from C6/36 cells was inhibited by
collagen IV (Fig. 1A).
Fig. 1. Inhibition of RR virus-induced cytopathic effect (CPE) by extracellular matrix (ECM) proteins and heparin. HeLa cells were seeded in quadruplicate
into 96-well plates and cultured overnight. (A) Collagen, laminin, or fibronectin were then added to the wells for an hour at the indicated concentrations before
addition of RR virus derived from HeLa cell cultures (RR xHeLa), RR virus derived from C6/36 cell cultures (RR xC6/36), and BF, SF, or SES virus (derived
from HeLa cell cultures). After culture for 48 h at 37 -C and 5% CO2, the cells remaining attached to the plate were fixed and stained using crystal violet
protein stain. The stain was eluted in methanol and read at OD595. An OD reading equivalent to the OD reading from wells without virus meant that no cells
were killed by the virus and represents 0% CPE or 100% inhibition of CPE. Zero percent inhibition of CPE means that the blocking agent failed to reduce the
CPE or increase the OD compared to the control wells, which contained virus but no blocking agent. These latter wells always showed >80% CPE. (B) Heparin
was incubated with the virus for 1 h before addition to the wells containing the cells. This protocol was adopted, since the virus may interact with heparin,
whereas collagen interacts with the cells. The plates were then cultured for 48 h and inhibition of CPE calculated as above.
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CPE
Cells can bind collagen via a number of heterodimeric
integrin receptors. Four integrins are currently recognized as
collagen receptors; a1h1 and a2h1, and the recently
identified a10h1 and a11h1 integrins (Gullberg and
Lundgren-Akerlund, 2002). To determine whether RR virus
uses collagen-binding integrins as receptors, a panel of
antibodies specific for the h1, h2, a1, and a2 integrin
proteins was tested for their ability to inhibit RR virus-
mediated CPE of HeLa cells. A monoclonal anti-h1
antibody was able to inhibit RR virus-mediated CPE, butnot CPE mediated by SES or SN virus (Fig. 2A, anti-h1
61.2.C4). A monoclonal antibody specific for h2 integrin
failed effectively to block RR virus-mediated CPE (Fig. 2A,
RR anti-h2 HB203). Monoclonal antibodies specific for a1
(FB12) and a2 (P1E6) were also individually able to inhibit
RR virus-induced CPE by about 35%, but had no inhibitory
activity against SES virus infections (Fig. 2A, anti-a1 FB12
and anti-a2 P1E6). An anti-a5 (FB12) monoclonal antibody
showed no blocking activity against RR or SES virus (Fig.
2A, anti-a5 FB12). An irrelevant anti-CD3 monoclonal
antibody also failed to inhibit RR virus-mediated CPE (data
not shown). In addition, a polyclonal goat anti-h1 antibody
(Fig. 2B, anti-h1 172, black squares) was able to inhibit RR
Fig. 2. RR virus-induced CPE is blocked by anti-h1 and anti-a1 antibodies. HeLa cells were set up as for Fig. 1 and antibody incubated with the cells for an
hour at the indicated concentrations before addition of virus. Percent inhibition was calculated as for Fig. 1. (A) Testing of blocking monoclonal antibodies
specific for integrin subunits (a1, a2, a5, h1, and h2) at the concentrations indicated against RR (black squares), SES (white squares), and SN (line) virus-
mediated CPE. (B) Testing of polyclonal goat anti-h1 serum (anti-h1 172) (black squares) and normal goat serum (NGS, white squares) at the indicated serum
dilutions against RR virus-mediated CPE.
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effect (Fig. 2, NGS, white squares).
These experiments indicate that RR virus uses h1
integrin to infect HeLa cells and suggests that both a1h1
and a2h1 integrins may represent receptors used by RR
virus to infect these cells. Due to the lack of available
reagents, we were unable to explore the role of a10h1 and
a11h1 integrins as RR virus receptors.
RR virus binds to soluble a1b1 integrin
To determine whether h1 integrins could also act as
binding receptors for RR virus, the ability of RR virus to
bind a panel of soluble integrins was investigated using C6/
36-derived RR virus (T48). Recombinant purified soluble
integrins, devoid of their membrane anchor and cytoplasmic
domains, were used to probe RR virus immobilized on
ELISA plates. Integrins undergo a conformational change,
which increases their affinity for the ligand and the 9EG7
antibody holds the integrin in the high affinity conforma-
tion. Furthermore, divalent cations like manganese (Mn2+)
are a requirement for integrin binding. Using an anti-h1
integrin antiserum to detect binding of soluble integrins toimmobilized RR virus, RR virus was shown to bind soluble
a1h1 integrin in the presence of Mn2+ and the 9EG7
antibody (Fig. 3, a1h1 + Mn/9EG7). This binding to RR
virus was lost when divalent cations (i.e., Mn2+) were
chelated with EDTA, illustrating that the interaction was
cation dependent, a characteristic of integrin binding (Fig. 3,
a1h1 + EDTA). Strong binding of soluble a1h1 integrin
was observed for the collagen IV fragment, CB3, which
contains the a1h1 integrin binding site (Eble et al., 1993)
(Fig. 3, a1h1 + Mn/9EG7). As expected, this binding was
again lost on removal of divalent cations (Fig. 3, a1h1
+EDTA). None of the other soluble integrins tested bound
immobilized RR virus, although all bound their known
ligands (laminin 1 and 5, and collagen I) in the presence of
Mn2+ and 9EG7. None of the soluble integrins bound the
negative control ligand, immobilized bovine serum albumin
(BSA) (Fig. 3, BSA). These data provided evidence that RR
virus can bind a1h1 integrin and might therefore use this
receptor as a binding or capture receptor.
The relatively weak binding of RR virus compared to
collagen IV in these experiments (Fig. 3) likely reflects the
inability of these experiments to mimic the physiological
interaction of RR virus with integrin receptors. Much higher
Fig. 3. Soluble a1h1 integrin binds to immobilized RR virus. Laminin, RR
virus, bovine serum albumin (BSA), collagen I, or the a1h1-binding
fragment of collagen IV, CB3, was immobilized onto ELIZA plates. RR
virus binding to the plate was confirmed using a RR virus-specific antibody
(see Materials and methods). After blocking, the indicated soluble integrin
receptors (15 Ag/ml) were added in duplicate for 1 h with EDTA (which
prevents the cation dependent integrin binding) or Mn2+ (2 mM) plus the
monoclonal antibody 9EG7 (which increase the affinity of the integrin for
its ligand). After washing, bound integrins were fixed to the wells with
2.5% glutaraldehyde and were detected with a rabbit anti-h1 antiserum, an
alkaline phosphatase-labeled secondary antibody, and p-nitro-phenylphos-
phate substrate. Absorbance was measured in an ELISA reader at 405 nm
and 595 nm.
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physiological conditions between multiple E2 binding sites
on the virus and the integrin molecules restricted to
movement in two dimensions on the cell surface. However,
attempts to mimic physiological conditions more effectively
by testing for RR virus binding to immobilized integrins in
ELISA-based experiments were complicated by the inability
to wash away effectively unbound RR virus using washingFig. 4. Collagen IV peptides representing the a1h1-binding site block RR virus b
non-neutralizing anti-RR virus monoclonal antibody (D7). HeLa cells were (i) inc
and secondary antibody (No RR), (ii) incubated without peptide and with RR v
incubated with peptide followed by RR virus and staining with D7 and secondar
amino acid code. Underlined amino acids illustrate the crucial residues involvedbuffers that necessarily needed to be free of EDTA and
detergents (data not shown).
FACS-based assay for blocking of RR virus binding
To further explore whether a1h1 integrin might be
involved as a RR virus binding receptor, a FACS-based
assay was developed whereby RR virus (T48) bound to cells
was detected using a non-neutralizing anti-RR virus mono-
clonal antibody, D7. The a1h1 integrin binding site has
recently been mapped to a small region within the CB3
fragment of collagen IV and was shown to be centered
around critical aspartic acid (D) residues in the a1 chains
and an arginine (R) residue on the a2 chain of collagen IV
(Golbik et al., 2000). Short synthetic peptides representing
this binding site on collagen IV, PGPPGDQGPP from the
a1 chains and GAKGRAGFP from a2 (critical residues
underlined), were able to inhibit binding of RR virus to
HeLa cells (Fig. 4). A panel of other peptides representing
RR virus E2 sequences failed to inhibit binding
(TPPDIPDRTL—Fig. 4; IPDRTLLSQT, RTLLSQTAGN,
and YQLTTAPTDE—data not shown). Thus collagen IV
peptides representing the a1h1 integrin binding site were
able to inhibit RR virus binding to cells, further implicating
the a1h1 integrin as a RR virus cell-binding receptor.
RR virus (T48) grown in HeLa cells was used for these
experiments. However, since the HeLa cells used in the
FACS experiment were treated with trypsin prior to
incubation with RR virus, most of the cell-associated
heparin is likely to have been removed (Kobayashi et al.,
2000). Hence heparin is not excluded as a capture receptor
by these experiments.
Although PGPPGDQGPP and GAKGRAGFP could
inhibit binding in these FACS assays, we have been unable
to demonstrate significant inhibition of RR virus-mediated
CPE using these peptides in an experiment similar to those
shown in Fig. 1A (data not shown). We believe that our
collagen peptides may have insufficient affinity for a1h1inding. FACS profiles of RR virus bound to HeLa cells detected using the
ubated without peptide and without RR virus followed by staining with D7
irus followed by staining with D7 and secondary antibody (RR), and (iii)
y antibody (RR + peptide). Peptide sequences are indicated in single letter
in a1h1-binding.
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collagen helix (Renner et al., 2004), which represents the
a1h1 integrin binding site (Eble et al., 1993).
Expression of a1 integrin correlates with RR virus infection
To further investigate the importance of a1h1 integrin in
RR virus infection, embryonic fibroblasts from a1 integrin
deficient (a1-KO) mice (Gardner et al., 1999) were infected
with serial 10-fold dilutions of different alphaviruses and the
cells fixed 3–5 days later before full CPE were observed in
wells receiving the least diluted virus (log10
1 virus
dilution). RR virus T48 derived from HeLa cells, RR virus
T48 derived from C6/36 cells, and RR14389 virus (derived
from HeLa) showed significantly lower CPE at log104,
log104, and log105 virus dilutions, respectively, on
fibroblasts from a1-KO mice compared with control
fibroblasts from wild-type mice (Fig. 5, RR T48 xHeLa,
RR T48 xC6/36, and RR14389). BF virus showed slightly
less CPE in a1-KO fibroblasts, whereas SN and SES and
SN virus showed similar or marginally more CPE in a1-KO
fibroblasts (Fig. 5). These studies not only support the view
that RR virus uses a1h1 integrin as a receptor, but also
illustrated that RR virus is able use other receptors in these
embryonic cells. As the virus concentrations increase, the
lack of a1 integrin has less effect on CPE, suggesting that
other receptors compensate for loss of a1 integrin when the
MOI increases. To determine whether anti-murine integrin
antibodies could further reduce infection of a1-KO embryo
fibroblasts, anti-murine a1 (Ha31/8), anti-murine a2
(HMa2), anti-murine h1 (Ha2/5), and anti-murine h2
(GAME-46) were tested in experiments similar to those
described in Fig. 2. None of these antibodies showed any
ability to further reduce infectivity of a1 KO fibroblasts by
RR virus or to reduce infectivity of these cells by the otherFig. 5. Reduced RR virus-mediated cytopathic effect (CPE) on embryonic fibrob
diamonds) and a1/ (white circle) mice were infected with 10-fold serial dilution
crystal violet staining and expressed as a percentage of control uninfected cells. For
CPE for a1/ and wild-type fibroblasts was significantly different ( P = 0.001, unp
C6/36 cells at log104 virus dilution ( P = 0.049) and RR14389 at log105 virusalphaviruses (data not shown). These experiments suggest
that these embryonic murine cells have receptors for
alphaviruses that do not involve h1 or h2 integrins. It
might be noted that RR virus infection of new born mice is
associated with paralysis and muscle pathology, whereas
infection of adult mice is asymptomatic (Lidbury et al.,
2000; Vrati et al., 1986).
A number of non-adherent human cell lines (Mono Mac
6, HL-60, K562), which are poorly infected by RR virus,
show no or weak staining for a1 and a2 integrin by FACS
analysis (data not shown).Discussion
This paper provides evidence that RR virus utilizes the
collagen IV-binding h1 integrin, a1h1, as a receptor in
mammalian cells. Integrins are well recognized as receptors
for a number of unrelated viruses including rotavirus,
hantavirus, echovirus, adenovirus, coxsackie virus, cytome-
galovirus, foot and mouth disease virus, and West Nile virus
(Chu and Ng, 2004; Duque et al., 2004; Feire et al., 2004;
Gavrilovskaya et al., 1999; White, 1993). However, to our
knowledge, this represents the first report of a virus utilizing
a1h1 integrin as a receptor. Collagen-binding h1 integrins
are nearly universally expressed on adherent cells (Gullberg
and Lundgren-Akerlund, 2002), and are also well conserved
in vertebrates (Hynes, 1992). The ability of RR virus to
infect most adherent mammalian cells (Linn et al., 1996)
and many different vertebrate species is consistent with the
use of this receptor. However, like rotaviruses (Guerrero et
al., 2000; Londrigan et al., 2000), RR virus appears able to
use more than one receptor. Additional receptors may
include the collagen-binding integrin receptors (a1h1,
a2h1, a10h1, and a11h1), integrins, or non-integrinlasts derived from a1/ mice. Fibroblasts from wild-type control (black
s of six alphaviruses and after 5 days the level of CPE was measured using
RRV T48 derived from HeLa cells at log104 virus dilution, the percentage
aired Student’s t test). This was also the case for RR virus T48 derived from
dilution ( P = 0.037).
M. La Linn et al. / Virology 336 (2005) 229–239 235collagen receptors (Gullberg and Lundgren-Akerlund,
2002), with infection of murine embryonic fibroblasts able
to occur independently of h1 or h2 integrins.
The cell-receptor binding domain for RR virus E2
appears to lie between amino acids 170 and 262, and phage
display analysis has placed components of the recognition
sites of two RR virus neutralizing antibodies around
E2 172 – 182 (PPDIPDRTLLS) and E2 234 – 248
(KWQFTSPFVPRADQT) (Davies et al., 2000). Interest-
ingly, these two regions include a number of highly
conserved amino acids in the SF group of alphaviruses that
use mammals as their enzootic vertebrate hosts (Fig. 6,
underlined sequences). Furthermore, these E2 regions show
some similarities with collagen IV sequences known to act
as the a1h1 integrin binding site, PGPPGDQGPP (from the
a1 chain of collagen) and GAKGRAGFP (from the a2
chain of collagen). The E2 and collagen IV sequences both
contain the characteristic P and/or G residues of collagen
and the crucial R and D residues (underlined), which in the
collagen sequences are known to be required for a1h1
integrin binding to collagen IV (Golbik et al., 2000). This
level of homology may not appear high. However, the
multiple ligands for a1h1 and a2h1 integrins, which
include several collagen types, laminin, certain virus
receptors (Graham et al., 2003), and certain snake venoms
(Eble and Tuckwell, 2003), also only show limited sequence
homology.
The ability to block infection using the CPE assays
described herein probably requires both high-affinity block-
ing agents and restricted use by the virus of other receptors
that can compensate for loss of the receptor targeted by the
blocking agent. The inability of collagen I to block RR virus
infection probably reflects its low affinity for the a1h1
integrin (Tulla et al., 2001). In contrast, collagen IV, which
has a high affinity for a1h1 integrin (Tulla et al., 2001), was
clearly able to mediate detectable blocking (Fig. 1A). Even
collagen I’s affinity for its preferred receptor, the a2h1Fig. 6. Wu Kabat analysis of region of E2 from the SF virus group believed to be i
and the variability index calculated, as described (Wu and Kabat, 1970), from the
Ora virus (AAC97207), o’nyong-nyong (AAC97205), RR/1 (AAA47404), RR/2 (P
The underlined sequences are postulated to be involved in contact with the celluintegrin, may be too low to mediate effective blocking, since
anti-a2 antibody, but not collagen I, partially inhibited RR
virus infection (Figs. 1A and 2). To our knowledge, there
are no reports of collagen I inhibiting infection of viruses
known to use a2h1 integrin as a receptor, further supporting
the view that standard collagen I preparations may not be
useful reagents for blocking virus infection via the a2h1
integrin receptor. The relatively low affinity interaction
between collagen IV and the a2h1 integrin probably also
renders collagen IV unable to block effectively infection via
the a2h1 integrin in such experiments. The inability of
collagen IV to block effectively infection of SF and SES
virus (Fig. 1B) does not provide evidence that these viruses
do not utilize the a1h1 integrin, since for these viruses other
receptors (e.g., a2h1 integrin) may be able to compensate
for loss of infection via the a1h1 integrin. RR and BF
viruses appear to have a preference for a1h1 integrin, with
no other receptors present on HeLa cells able to compensate
sufficiently when this receptor is blocked.
It is tempting to speculate that the use of collagen
receptors by RR virus and BF virus is related to the
induction of polyarthritic disease by these viruses in
humans. Not all individuals infected with RR virus develop
RRVD (Harley et al., 2001) and the factors that predispose
to symptomatic seroconversion remain elusive. Expression
of platelet a2h1 integrin (GPIa/IIa) has been shown to vary
up to 10-fold in different individuals due to allelic variation
in the gene encoding a2 (Kritzik et al., 1998), and h3
integrin (GPIIIa) contains polymorphisms that effect its
function (Kunicki and Nugent, 2002). Although to date no
such polymorphisms have been identified in a1h1 integrin
genes, genetic variation in RR virus receptors might
influence predisposition to symptomatic RR virus infection.
However, perhaps a more compelling association between
a1h1 integrin usage and arthritis comes from recent studies
showing that anti-a1 and a2-integrin antibodies can block
several in vivo models of inflammation including anti-nvolved in receptor binding. The E2 sequence of RR/1 (154–253) is shown
following sequences; BF (AAB40702), chikungunya virus (L37661), Igbo
08491), Sagiyama virus (BAA92847), SF (X78112), and SES (AF315122).
lar receptor (Davies et al., 2000).
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of migration or activation of monocytes (de Fougerolles et
al., 2000). The arthritic symptoms of RRVD are associated
with inflammatory synovial infiltrates comprised primarily
of monocytes and macrophages (Fraser et al., 1981). RR
virus has also been detected in such infiltrates in vivo many
weeks after disease onset (Soden et al., 2000) and RR virus
can establish persistent productive cytopathic infections in
macrophage cultures in vitro (Linn and Suhrbier, 1997;
Suhrbier and Linn, 2004; Way et al., 2002). Furthermore,
such cultures secrete IL-8 (CXCL8), monocyte chemo-
attractant protein-1 (CCL2), and macrophage inflammatory
protein-2 (CXCL2) (Mateo et al., 2000; Way et al., 2002),
chemokines involved in monocyte recruitment and activa-
tion (Gerszten et al., 1999). Monocytes express only low
levels of a1h1, but upon activation and differentiation into
macrophages expression is rapidly upregulated (Rubio et
al., 1995), consistent with the ability of RR virus to infect
macrophages, but not monocytes in vitro (Linn et al.,
1996). Development of arthritis may be dependent on
access of RR virus into joint tissues, a process that might
be facilitated by the existence during the short viremic
period of subclinical inflammatory joint lesions containing
macrophages with high a1h1 integrin expression. Infection
and/or viral persistence in the joint may also be expedited
by the continued recruitment into the inflamed joint of
monocytes that rapidly upregulate expression of a RR virus
receptor.Materials and methods
Cells
HeLa cells (ATCC CCL-2) were propagated in RPMI
1640 supplemented with 10% fetal bovine serum (FBS), 2
mM l-glutamine, 10 mM HEPES, 100 U/ml penicillin G
sodium, and 100 Ag/ml streptomycin sulphate. K-562
(ATCC CCL-243), Mono Mac 6 (Ziegler-Heitbrock et al.,
1988), and HL-60 (ECCC 88120805) were cultured as
above in medium shown to contain <0.05 ng/ml lip-
opolysaccharide (Sweet and Hume, 1995), equivalent to
<0.025 endotoxin units by Limulus Amebocyte Lysate assay
(BioWhitiker). Murine fibroblast cell lines derived from
integrin alpha1/ mice (Gardner et al., 1999) and control
wild-type mice were cultured in Dulbecco’s modified
Eagle’s medium supplemented with 15% fetal bovine serum
(FBS), 2 mM l-glutamine, 10 mM HEPES, 0.01 mM MEM
non-essential amino acids, and antibiotics. The vertebrate
cell lines were cultured at 37 -C in 5% CO2. The
invertebrate C6/36 cells (ATCC CRL 1660) were grown
in RPMI 1640 media supplemented with 10% FBS, 0.01
mM MEM non-essential amino acids, 2 mM l-glutamine,
10 mM HEPES, and antibiotics, and were incubated at 30
-C in 5% CO2. All cell culture reagents were purchased
from Gibco, Invitrogen, Melbourne, Victoria, Australia.Alphaviruses
Stocks of (i) RR virus T48 strain, (ii) RR virus 14389
strain (Doherty et al., 1972), (iii) Semliki Forest virus
(supplied by P. Hertzog, Monash University, Victoria,
Australia), (iv) SN virus (provided by R. Hall, University
of Queensland, Queensland, Australia), (v) Barmah Forest
(provided by B. Kay, Queensland Institute of Medical
Research), and (vi) Southern elephant seal virus (SES)
(Linn et al., 2001) were prepared by infecting a sub-
confluent monolayer of HeLa cells or C6/36 cells in T75
culture flasks (Corning). The cell culture fluid was
harvested between 18 and 26 h and centrifuged at 1000 
g (Beckman GS-15R centrifuge) for 30 min at 4 -C to
remove cellular debris. The supernatant was dispensed into
small aliquots and stored at 70 -C. Polyethylene glycol
(PEG)-purified RR virus (T48) was a generous gift from
PanBio Pty Ltd, Australia. The purified RR virus was
inactivated by exposure to 960 AW/cm2 of UV-C for 2 h
(Linn et al., 1996) prior to use in the soluble integrin
binding ELISA. All cells lines and viruses were negative for
mycoplasma (Linn et al., 1995).
Inhibition by of virus-induced cytopathic effect (CPE)
The dilutions of virus stocks that killed >80% of cells in
48 h were used in these assays. Virus was added in
quadruplicate into 96-well plates seeded with 104 HeLa cells
on the previous day. CPE was determined 48 h post-
infection by fixation and staining of infected and uninfected
control cells with 0.05% crystal violet and 10% form-
aldehyde in phosphate-buffered saline. After washing with
water and air drying, the level of CPE was measured by
eluting the crystal violet stain taken up by living cells with
100% methanol and reading at OD595 (VERSAmax micro-
plate reader, Molecular Devices). Percent killing was
calculated as (mean OD of uninfected cell control wells
[without virus])  (mean OD of wells infected with virus) /
(mean OD of uninfected cell control wells [without virus]).
Percent inhibition of CPE was calculated as (percentage
killing of cells by virus alone)  (percentage killing of cells
with blocking agent)/(percentage killing of cells by virus
alone).
For inhibition by extracellular matrix proteins, HeLa
cells were incubated at room temperature for 1 h with serial
dilutions of (i) bovine collagen I or bovine collagen II
prepared as described previously (Rowley et al., 1986), (ii)
collagen IV from Engelbreth–Holm–Swarm murine sar-
coma basement membrane (Sigma), (iii) fibronectin from
human plasma (Sigma), or (iv) laminin from human
placenta (Sigma). Virus was then added and the cells
cultured for 48 h. For inhibition by heparin, virus was
incubated with serial dilutions of sodium heparin (from
porcine and bovine mucous, Pharmacia and Upjohn Pty Ltd,
Perth, Australia) at room temperature for 1 h before addition
of 100 Al of the heparin virus mixture to a HeLa cell
M. La Linn et al. / Virology 336 (2005) 229–239 237monolayer in 100 Al of medium, followed by incubation for
48 h before fixation.
For inhibition by anti-integrin antibodies, HeLa cells
were incubated with serial dilutions of anti-integrin anti-
bodies at room temperature for 1 h and followed by addition
of virus and culture for 48 h. The following blocking anti-
integrin monoclonal antibodies were used: antihuman
integrin a1 (FB12), antihuman integrin a2 (P1E6), anti-
human integrin a5 (FB12) (Chemicon Australia Pty Ltd),
antihuman integrin h1 (61.2C4), and antihuman integrin h2,
(HB203) (generous gifts from J. Gamble, the Hanson
Institute, Adelaide, South Australia). The goat polyclonal
antihuman h1 antibody (serum 172) was provided by M.
Ginsberg (Scripps Research Institute, La Jolla, USA). The
control monoclonal antibody was anti-CD3 (IOT3b) (Immu-
notech S.A., Marseille, France). The blocking anti-murine
integrin antibodies were anti-murine a1 (Ha31/8), anti-
murine a2 (HMa2), anti-murine h1 (Ha2/5), and anti-
murine h2 (GAME-46) (BD Biosciences Pharmingen).
Blocking of RR virus binding assay
A single cell suspension of HeLa cells was prepared
by treating HeLa cell monolayers with trypsin-EDTA and
washing once with phosphate-buffered saline containing
2% FCS (PBS-2). Cell pellets of 2  105 cells were
incubated with 40 Al of 2 mg/ml of the following
peptides, PGPPGDQGPP, GAKGRAGFP (Collagen IV),
TPPDIPDRTL, IPDRTLLSQT, RTLLSQTAGN, and
YQLTTAPTDE (RR virus E2) (Chiron Technologies,
Clayton, Victoria, Australia), for 1 h at 4 -C and followed by
incubation with 10 Al of RR virus (virus to cell ratio of 10
CCID50:1) for 1 h at 4 -C. Unbound virus was washed off
with PBS-2 and HeLa cell-bound RR virus was detected by
incubating with 1:10 dilution of an anti-RR virus D7
antibody hybridoma culture supernatant for 30 min at 4
-C; (D7 is a non-neutralizing anti-RR virus mouse mono-
clonal antibody provided by J. Aaskov, Queensland Uni-
versity of Technology, Queensland, Australia). After three
washes with PBS-2, cells were incubated with FITC-
conjugated sheep F(abV)2 anti-mouse (Silenus, Australia)
for 30 min at 4 -C, washed twice, and analyzed by FACScan
flow cytometer (Becton Dickinson) using the cellQuest
software.
Soluble integrin binding ELISA assay
Preparation and purification of recombinant soluble
integrins, and the soluble integrin binding ELISA assay,
were carried out at the Institut fu¨r Physiologische Chemie
und Pathobiochemie, Germany, as described previously
(Eble and Tuckwell, 2003; Eble et al., 1998, 2001; Golbik et
al., 2000). Microtiter plate wells (Greiner, Nuertingen,
Germany) were coated at 4 -C overnight with 100 Al of
10 Ag/ml of CB3 (Vandenberg et al., 1991), bovine
collagen-1 (prepared by standard protocol), human lami-nin-1 (a kind gift from R Timpl, Max-Planck-Institute for
Biochemistry, Munich, Germany), human laminin-5 (Rous-
selle et al., 1991), or UV-inactivated purified RR virus in 50
mM Tris–HCl, pH 7.4, 150 mM NaCl (TBS). After
washing three times with TBS containing 2 mM MgCl2
(TBS-Mg), the wells were blocked with 1% denatured
bovine serum albumin (Sigma) in TBS-Mg (BSA-TBS-Mg)
for 2 h at room temperature. The presence of immobilized
RR virus was confirmed by ELISA using a polyclonal rabbit
anti-RR virus (T48) antibody (kind gift from Dr Aaskov,
Queensland University of Technology, Australia), which
had a neutralization index of 5.5 at 1:10 dilution (data not
shown). When used at 1:100 dilution followed by anti-rabbit
HRP and ABTS substrate (Sigma), RR virus-coated plates
generated an OD 405 of 1.7 T 0.2 SD, whereas control sera
gave an OD of 0.25 T 0.05. After blocking, the soluble
integrins (15 Ag/ml diluted in TBS-Mg containing 1 mM
MnCl2) and activating anti-h1 rat MAb 9EG7 (kindly
provided by D. Vestweber, University Munster, Germany)
were added to the plates for 2 h at room temperature in the
presence and absence of 10 mM EDTA. The wells were
washed twice with HEPES buffer (50 mM HEPES, 150 mM
NaCl, 2 mM MgCl2, 1 mM MnCl2 with or without 10 mM
EDTA). The bound integrins were then fixed to the wells
with 2.5% glutaraldehyde in HEPES buffer for 10 min at
room temperature and washed three times with TBS-Mg.
The bound soluble integrins were then detected using rabbit
anti-h1 antiserum (Eble and Tuckwell, 2003) (diluted 1:400
in BSA-TBS-Mg) and alkaline phosphatase-conjugated anti-
rabbit IgG (1:600 in BSA-TBS-Mg) (Sigma) for 1.5 h each
at room temperature, with three washes with TBS-Mg after
each incubation. The color was developed with p-nitro-
phenylphosphate (pNpp) (Sigma) in a 0.1 M glycine-buffer,
pH 10.4, supplemented with 1 mM MgCl2 and 1 mM Zn-
acetate. The color reaction was stopped by addition of 1.5 M
NaOH solution, and absorbance was measured in an ELISA
reader (Dynatech, Germany) at 405 nm and 595 nm (Eble
and Tuckwell, 2003).
Surface expression of integrin receptors
Cells (2  105) were washed with PBS-2 and blocked
with 5% normal human immunoglobulin (CSL Pty Ltd,
Australia) for 25 min at 4 -C, followed by incubation with 2
Ag of anti-integrin (FB12 or P1E6) or isotype control
monoclonal antibody for 30 min at 4 -C. After three washes
with PBS-2, cells were incubated with anti-mouse IgG-
FITC for 30 min at 4 -C and analyzed by FACS as above.Acknowledgments
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